{"count":10,"index":{"built_at":"2026-07-28T03:55:14.074656+00:00","public_records":55311,"revision":"87a26518b7a5d480d14c11e6"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Myths vs Facts: CYP2C19 und sleep"},"results":[{"answer":"CYP2C19 is primarily a drug-metabolizing enzyme, involved in breaking down medications like clopidogrel and proton pump inhibitors. There is no robust scientific evidence that CYP2C19 variants directly affect sleep. Claims from direct-to-consumer tests linking CYP2C19 to sleep quality or duration are mostly speculative or based on indirect effects via drug metabolism. For example, individuals with slow CYP2C19 metabolism might experience enhanced sedation when taking certain sleep aids (e.g., some benzodiazepines), but that is a pharmacogenetic effect, not a direct genetic influence on sleep. The evidence is weak and relies on mechanistic reasoning or small studies. For sleep optimization, lifestyle factors such as sleep hygiene, stress management, and light exposure are far more relevant than CYP2C19. Consumers should be skeptical of exaggerated claims derived from genetic tests.","area":"gesundheit","canonical_id":"gesundheit:canonical-43bf028b2313f43bdc25ce6f","id":"public-91f25d3fead5ea76523976c6","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP2C19 and sleep","score":29.63336971,"snippet":"CYP2C19 is primarily a drug-metabolizing enzyme, involved in breaking down medications like clopidogrel and proton pump inhibitors. There is no robust scientific evidence that CYP2C19 variants directly affect sleep. Claims from direct-to-consumer tests linking CYP2C19 to sleep quality or duration are mostly speculative or based on indirect effects via drug metabolism. For example, individuals with slow CYP2C19 metabolism might experience enhanced sedation when taking certain sleep aids (e.g., some benzodiazepines), but that is a pharmacogenetic effect, not a direct genetic influence on sleep. The evidence is weak and relies on mechanistic reasoning or small studies. For sleep optimization, l","sources":[],"title":"Myths vs facts: CYP2C19 and sleep","url":"https://tikki.wiki/wissen/gesundheit/frage/public-91f25d3fead5ea76523976c6/myths-vs-facts-cyp2c19-and-sleep/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Die Frage nach Mythen vs. Fakten zu CYP2C19 und Schlaf lässt sich aus dem vorliegenden Kontext nicht beantworten, da keiner der Einträge CYP2C19 oder Schlaf thematisiert. CYP2C19 ist ein Enzym des Arzneimittelstoffwechsels, das vor allem für die Verarbeitung von Medikamenten wie Clopidogrel, Protonenpumpenhemmern und bestimmten Antidepressiva bekannt ist. Ein direkter, klinisch relevanter Einfluss von CYP2C19-Varianten auf den Schlaf ist in der Literatur nicht etabliert. Behauptungen, wonach ein Gentest auf CYP2C19 Schlafqualität oder -störungen vorhersagen könne, entbehren der wissenschaftlichen Evidenz. Solche Aussagen sind meist marketinggetrieben und überschätzen die tatsächliche Aussagekraft. Die einzige plausible Verbindung wäre indirekt: über die Verstoffwechselung von Schlafmitteln oder Antidepressiva, aber selbst hier sind die Effekte gering und nicht für die Allgemeinbevölkerung relevant. Ohne spezifische Studien oder Kontext bleibt die Evidenzlage unklar. Verbraucher sollten skeptisch sein, wenn ein DNA-Test angeblich Schlafprobleme durch CYP2C19 erklärt.","area":"gesundheit","canonical_id":"gesundheit:canonical-6006d6b577564b3c1906a7da","id":"public-b5f4c2e1521c59940ca11c76","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: CYP2C19 und sleep","score":29.58393297,"snippet":"Die Frage nach Mythen vs. Fakten zu CYP2C19 und Schlaf lässt sich aus dem vorliegenden Kontext nicht beantworten, da keiner der Einträge CYP2C19 oder Schlaf thematisiert. CYP2C19 ist ein Enzym des Arzneimittelstoffwechsels, das vor allem für die Verarbeitung von Medikamenten wie Clopidogrel, Protonenpumpenhemmern und bestimmten Antidepressiva bekannt ist. Ein direkter, klinisch relevanter Einfluss von CYP2C19-Varianten auf den Schlaf ist in der Literatur nicht etabliert. Behauptungen, wonach ein Gentest auf CYP2C19 Schlafqualität oder -störungen vorhersagen könne, entbehren der wissenschaftlichen Evidenz. Solche Aussagen sind meist marketinggetrieben und überschätzen die tatsächliche Aussage","sources":[],"title":"Myths vs Facts: CYP2C19 und sleep","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b5f4c2e1521c59940ca11c76/myths-vs-facts-cyp2c19-und-sleep/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"A common myth is that CYP2C19 gene variants directly cause sleep disorders. In reality, CYP2C19 encodes a liver enzyme that metabolizes various drugs, including certain antidepressants (e.g., citalopram), proton pump inhibitors, and the sleep aid diazepam. Variants can alter how quickly these drugs are processed, which may indirectly affect sleep quality—for example, if a medication is less effective or causes side effects. However, without medication, CYP2C19 has no significant direct impact on sleep. Claims that CYP2C19 variants alone cause insomnia or sleep apnea are not supported by evidence. Sleep is regulated by a complex interplay of genetics, environment, behavior, and other genes (e.g., CLOCK, PER3). Consumer DNA tests often overstate the role of single genes. If you experience sleep issues, focus on proven factors like sleep hygiene, stress reduction, and medical evaluation—not on a single genetic test.","area":"gesundheit","canonical_id":"gesundheit:canonical-76ce23514db98b2f7f7beb98","id":"public-85b10fa33901c3dabe710ac6","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP2C19 and Schlaf","score":29.499886,"snippet":"A common myth is that CYP2C19 gene variants directly cause sleep disorders. In reality, CYP2C19 encodes a liver enzyme that metabolizes various drugs, including certain antidepressants (e.g., citalopram), proton pump inhibitors, and the sleep aid diazepam. Variants can alter how quickly these drugs are processed, which may indirectly affect sleep quality—for example, if a medication is less effective or causes side effects. However, without medication, CYP2C19 has no significant direct impact on sleep. Claims that CYP2C19 variants alone cause insomnia or sleep apnea are not supported by evidence. Sleep is regulated by a complex interplay of genetics, environment, behavior, and other genes (e","sources":[],"title":"Myths vs facts: CYP2C19 and Schlaf","url":"https://tikki.wiki/wissen/gesundheit/frage/public-85b10fa33901c3dabe710ac6/myths-vs-facts-cyp2c19-and-schlaf/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications like clopidogrel, proton pump inhibitors, and some antidepressants. Myths in sports claim that CYP2C19 variants predict athletic performance, recovery, or injury risk. The facts: no robust human studies show a direct link between CYP2C19 and sport outcomes. Evidence is limited to pharmacogenetic effects (e.g., altered painkiller or caffeine metabolism) that might indirectly affect training. MyBody-X tests include CYP2C19 in a nutrigenetic context, but without sport-specific validation. There is no 'athlete gene' here. Effect sizes are small, and lifestyle factors (diet, sleep, training) are far more influential. Be cautious of marketing hype. For medication-related questions, always consult a physician.","area":"gesundheit","canonical_id":"gesundheit:canonical-1fe66d21400d6bbc56605cda","id":"public-2272b0de54290ea5d4292c4a","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP2C19 and Sport","score":28.84523772,"snippet":"CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications like clopidogrel, proton pump inhibitors, and some antidepressants. Myths in sports claim that CYP2C19 variants predict athletic performance, recovery, or injury risk. The facts: no robust human studies show a direct link between CYP2C19 and sport outcomes. Evidence is limited to pharmacogenetic effects (e.g., altered painkiller or caffeine metabolism) that might indirectly affect training. MyBody-X tests include CYP2C19 in a nutrigenetic context, but without sport-specific validation. There is no 'athlete gene' here. Effect sizes are small, and lifestyle factors (diet, sleep, training) are far more influentia","sources":[],"title":"Myths vs facts: CYP2C19 and Sport","url":"https://tikki.wiki/wissen/gesundheit/frage/public-2272b0de54290ea5d4292c4a/myths-vs-facts-cyp2c19-and-sport/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Claims linking CYP2C19 variants directly to skin aging lack scientific support. CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications like clopidogrel and proton pump inhibitors. Some direct-to-consumer tests market a connection to oxidative stress or detoxification, but no robust human studies demonstrate a causal or predictive relationship between CYP2C19 polymorphisms and skin aging (wrinkles, elasticity, collagen degradation). Evidence is limited to speculative mechanisms from in vitro or animal models. Skin aging is predominantly driven by UV exposure, lifestyle factors (smoking, diet), hormones, and intrinsic genetic factors such as collagen-related genes. A CYP2C19 test for skin aging prediction is not evidence-based and may create false expectations. Consumers should focus on proven anti-aging strategies: sun protection, healthy diet, adequate sleep, and dermatological advice. The evidence for CYP2C19 and skin aging is rated as 'unclear'.","area":"gesundheit","canonical_id":"gesundheit:canonical-07672e956dc8d7520bd1a746","id":"public-51fe9180605a42da75325593","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP2C19 and skin aging","score":28.33993353,"snippet":"Claims linking CYP2C19 variants directly to skin aging lack scientific support. CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications like clopidogrel and proton pump inhibitors. Some direct-to-consumer tests market a connection to oxidative stress or detoxification, but no robust human studies demonstrate a causal or predictive relationship between CYP2C19 polymorphisms and skin aging (wrinkles, elasticity, collagen degradation). Evidence is limited to speculative mechanisms from in vitro or animal models. Skin aging is predominantly driven by UV exposure, lifestyle factors (smoking, diet), hormones, and intrinsic genetic factors such as collagen-related genes. ","sources":[],"title":"Myths vs facts: CYP2C19 and skin aging","url":"https://tikki.wiki/wissen/gesundheit/frage/public-51fe9180605a42da75325593/myths-vs-facts-cyp2c19-and-skin-aging/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The claim that CYP2C19 variants directly influence weight loss is largely a myth. CYP2C19 is a liver enzyme primarily involved in drug metabolism (e.g., clopidogrel, proton pump inhibitors). There is no strong human evidence linking CYP2C19 polymorphisms to body weight regulation, fat oxidation, or weight loss success. Some exploratory studies have suggested weak associations with omega-3 fatty acid metabolism or resting energy expenditure, but these findings are inconsistent, small in effect size, and not replicated. Direct-to-consumer DNA tests that market CYP2C19 as a 'weight loss gene' overstate the science. Weight loss is multifactorial, driven by energy balance, macronutrient composition, physical activity, sleep, and stress. Personalizing diet based on CYP2C19 is not evidence-based. The clinical utility of CYP2C19 remains in pharmacogenetics (drug dosing), not weight management. For evidence-based nutrigenetics, consider validated markers like FTO or MC4R, but always within a comprehensive lifestyle approach.","area":"gesundheit","canonical_id":"gesundheit:canonical-1ba457093c4bfbaa9113f4eb","id":"public-d765a490f431801909957664","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP2C19 and weight loss","score":28.27157204,"snippet":"The claim that CYP2C19 variants directly influence weight loss is largely a myth. CYP2C19 is a liver enzyme primarily involved in drug metabolism (e.g., clopidogrel, proton pump inhibitors). There is no strong human evidence linking CYP2C19 polymorphisms to body weight regulation, fat oxidation, or weight loss success. Some exploratory studies have suggested weak associations with omega-3 fatty acid metabolism or resting energy expenditure, but these findings are inconsistent, small in effect size, and not replicated. Direct-to-consumer DNA tests that market CYP2C19 as a 'weight loss gene' overstate the science. Weight loss is multifactorial, driven by energy balance, macronutrient compositi","sources":[],"title":"Myths vs facts: CYP2C19 and weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d765a490f431801909957664/myths-vs-facts-cyp2c19-and-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP2C19 is a drug-metabolizing enzyme in the cytochrome P450 family, primarily responsible for breaking down medications such as proton pump inhibitors (e.g., omeprazole), certain antidepressants, and clopidogrel. There is no direct, well-established link between CYP2C19 variants and blood sugar levels in healthy individuals. Some indirect mechanisms have been proposed: slow metabolizers may experience altered drug effects that secondarily influence gut microbiota or weight, which could modulate glucose metabolism. However, these associations are speculative, lack robust human evidence, and are not sufficient for personalized blood sugar recommendations. No official health authority (EFSA, DGE, WHO) adjusts dietary or glycemic targets based on CYP2C19 genotype. Consumer DNA tests often overstate weak or unreplicated associations. The evidence for a direct gene–blood sugar connection is unclear at best. For blood sugar management, focus on proven lifestyle factors: diet, physical activity, and sleep. Safety note: CYP2C19 status is clinically relevant for drug dosing, not for metabolic health in the general population.","area":"gesundheit","canonical_id":"gesundheit:canonical-1626d7be6b15c46a34e054f9","id":"public-a2bbe347a25e32acc3d8d94f","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: CYP2C19 and blood sugar","score":28.18515374,"snippet":"CYP2C19 is a drug-metabolizing enzyme in the cytochrome P450 family, primarily responsible for breaking down medications such as proton pump inhibitors (e.g., omeprazole), certain antidepressants, and clopidogrel. There is no direct, well-established link between CYP2C19 variants and blood sugar levels in healthy individuals. Some indirect mechanisms have been proposed: slow metabolizers may experience altered drug effects that secondarily influence gut microbiota or weight, which could modulate glucose metabolism. However, these associations are speculative, lack robust human evidence, and are not sufficient for personalized blood sugar recommendations. No official health authority (EFSA, D","sources":[],"title":"Myths vs facts: CYP2C19 and blood sugar","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a2bbe347a25e32acc3d8d94f/myths-vs-facts-cyp2c19-and-blood-sugar/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Die Kombination von Pharmakogenetik (PGx) und Schlaf wird oft mit Mythen überladen. Fakt ist: Bestimmte Genvarianten (z. B. in CYP2D6, CYP2C19, COMT, DRD2) können die Verstoffwechselung von Schlafmitteln wie Zolpidem, Melatonin oder Antidepressiva beeinflussen. Ein PGx-Test wie der Medicheck kann Hinweise auf langsame oder schnelle Metabolisierer geben – das ist evidenzbasiert (human-moderate bis gwas). Allerdings: Die Effekte sind klein, kontextabhängig und nicht für alle Schlafprobleme relevant. Mythos: Ein Gentest sagt Ihnen genau, welches Schlafmittel wirkt. Fakt: PGx liefert nur Wahrscheinlichkeiten; klinische Entscheidungen brauchen ärztliche Begleitung. Auch die Behauptung, PGx könne Schlafqualität direkt vorhersagen, ist übertrieben. Die vorliegenden Kontextdaten (COMT, DRD2, ALDH2) zeigen Assoziationen zu Dopamin- und Alkoholstoffwechsel, aber nicht spezifisch zu Schlaf. Vorsicht vor Marketing, das aus kleinen SNP-Effekten große Schlafversprechen ableitet. Sicherheitshinweis: Ändern Sie nie eigenmächtig Medikamente basierend auf einem Gentest. Konsultieren Sie einen Arzt oder Apotheker.","area":"gesundheit","canonical_id":"gesundheit:canonical-131158ea69022dc48d262fb3","id":"public-8a960493d134beaf3aa54b40","kind":"qa","language":"de","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs Facts: Pharmakogenetik Medicheck und sleep","score":27.48855649,"snippet":"Die Kombination von Pharmakogenetik (PGx) und Schlaf wird oft mit Mythen überladen. Fakt ist: Bestimmte Genvarianten (z. B. in CYP2D6, CYP2C19, COMT, DRD2) können die Verstoffwechselung von Schlafmitteln wie Zolpidem, Melatonin oder Antidepressiva beeinflussen. Ein PGx-Test wie der Medicheck kann Hinweise auf langsame oder schnelle Metabolisierer geben – das ist evidenzbasiert (human-moderate bis gwas). Allerdings: Die Effekte sind klein, kontextabhängig und nicht für alle Schlafprobleme relevant. Mythos: Ein Gentest sagt Ihnen genau, welches Schlafmittel wirkt. Fakt: PGx liefert nur Wahrscheinlichkeiten; klinische Entscheidungen brauchen ärztliche Begleitung. Auch die Behauptung, PGx könne ","sources":[],"title":"Myths vs Facts: Pharmakogenetik Medicheck und sleep","url":"https://tikki.wiki/wissen/gesundheit/frage/public-8a960493d134beaf3aa54b40/myths-vs-facts-pharmakogenetik-medicheck-und-sleep/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The idea that a skincare DNA test can provide meaningful insights about fatigue is a myth. These tests typically examine genes related to collagen, antioxidant defense, or pigmentation – not energy metabolism or sleep regulation. Fatigue is multifactorial: sleep disorders, stress, nutritional deficiencies (iron, vitamin D, B12), thyroid dysfunction, and mental health are far more relevant. Consumer DNA tests for ‚energy‘ or ‚longevity‘ (e.g., MTOR) lack clinical validation for fatigue assessment. The provided context shows that even for drug metabolism (CYP2D6/CYP2C19), results require clinical interpretation. For fatigue, evidence is marketing/unclear. A medical workup is essential. Skincare DNA tests are not a substitute for proper diagnosis.","area":"gesundheit","canonical_id":"gesundheit:canonical-a2fdaf6d13b24cc4d1d1b5bf","id":"public-de30c2ed8de55cf9f95120fd","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: Skincare DNA and Müdigkeit","score":27.38873209,"snippet":"The idea that a skincare DNA test can provide meaningful insights about fatigue is a myth. These tests typically examine genes related to collagen, antioxidant defense, or pigmentation – not energy metabolism or sleep regulation. Fatigue is multifactorial: sleep disorders, stress, nutritional deficiencies (iron, vitamin D, B12), thyroid dysfunction, and mental health are far more relevant. Consumer DNA tests for ‚energy‘ or ‚longevity‘ (e.g., MTOR) lack clinical validation for fatigue assessment. The provided context shows that even for drug metabolism (CYP2D6/CYP2C19), results require clinical interpretation. For fatigue, evidence is marketing/unclear. A medical workup is essential. Skincar","sources":[],"title":"Myths vs facts: Skincare DNA and Müdigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-de30c2ed8de55cf9f95120fd/myths-vs-facts-skincare-dna-and-muedigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Myths vs. Facts: Pharmacogenetics (Medicheck) and Sleep Myth: A DNA test like Medicheck can precisely predict which sleep medication will work for you and which won't. Fact: Pharmacogenetics can offer clues about how certain drugs are metabolized – e.g., via CYP2C19 or CYP2D6. For sleep medications such as zolpidem, melatonin, or sedating antidepressants, the evidence is limited and often conflicting. Most studies are mechanistic or based on GWAS, not on randomized controlled trials with sleep endpoints. Myth: The test replaces a doctor's prescription and dose adjustment. Fact: In Germany, pharmacogenetic tests are classified as wellness tools under the Genetic Diagnostics Act (GenDG), not as medical devices. They cannot diagnose conditions or replace clinical decisions. Actual drug response depends on dose, timing, co-medications, liver function, age, and lifestyle. Conclusion: Pharmacogenetics provides interesting but often weak signals. For sleep, the evidence is mostly mechanistic or associative. Always consult a physician for sleep issues – a genetic test alone is no substitute for proper medical evaluation.","area":"gesundheit","canonical_id":"gesundheit:canonical-343806981dca02d5942c5ec2","id":"public-9c2d5891be634756e8eec45b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Myths vs facts: Pharmakogenetik Medicheck and Schlaf","score":27.32897513,"snippet":"Myths vs. Facts: Pharmacogenetics (Medicheck) and Sleep Myth: A DNA test like Medicheck can precisely predict which sleep medication will work for you and which won't. Fact: Pharmacogenetics can offer clues about how certain drugs are metabolized – e.g., via CYP2C19 or CYP2D6. For sleep medications such as zolpidem, melatonin, or sedating antidepressants, the evidence is limited and often conflicting. Most studies are mechanistic or based on GWAS, not on randomized controlled trials with sleep endpoints. Myth: The test replaces a doctor's prescription and dose adjustment. Fact: In Germany, pharmacogenetic tests are classified as wellness tools under the Genetic Diagnostics Act (GenDG), not a","sources":[],"title":"Myths vs facts: Pharmakogenetik Medicheck and Schlaf","url":"https://tikki.wiki/wissen/gesundheit/frage/public-9c2d5891be634756e8eec45b/myths-vs-facts-pharmakogenetik-medicheck-and-schlaf/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}